References
- Archer J. A., Gorden P., Kahn C. R., Gavin J. R., Neville D. M., Martin M. M., Roth J. Insulin deficiency states in man: two clinical forms. J. clin. Invest. 1973; 52: 4
- Bender A. N., Ringel S, King P., Engel W., Daniels M. P. Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction. Lancet 1975; 1: 607
- Bernal J., deGroot L. J., Refetoff S. Absent nuclear T3 receptors with resistance to hormone action abstract. 7th International Thyorid Conference, Boston, June, 1975, 9–13
- Bourne H. R., Lichtenstein K. L., Melmon K. L., Henney C. S., Weinstein Y., Shearer G. M. Modulation of inflammation and immunity by cyclic AMP. Receptors for vasoactive hormones and mediators of inflammation regulate many leukocyte functions. Science 1974; 184: 19
- Campbell W. B., Brooks S. N., Pettinger W. A. Angiotensin-II- and angiotensin-III-induced aldosterone release in vivo in the rat. Science 1974; 184: 994
- Cuatrecasas P. Interaction of insulin with the cell membranes: the primary action of insulin. Proc. nat. Acad. Sci. (Wash.) 1969; 63: 450
- Cuatrecasas P. Problems in receptor identification: catecholamines. New Engl. J. Med. 1974; 291: 206
- Cuatrecasas P., Tell P. G. E., Sica V., Parikh I., Chang K. I. Noradrenaline binding and the search for cathecholamine receptors. Nature (Lond.) 1974; 247: 92
- Daniels M. P., VogeJ Z. Immunoperoxidase staining of et-bungarotoxin binding sites in muscle endplates shows distribution of acetylcholine receptors. Nature (Lond.) 1975; 254: 339
- Fyhrquist F., Goodfriend T. L. Angiotensin binding in plasma from seriously ill patients and an experimental dog model. J. Lab. clin. Med. 1971; 78: 816
- Gavin J. R., Roth J., Jen P., Freychet P. Insulin binding receptors in human circulating cells and fibroblasts. Proc. nat. Acad. Sci. (Wash.) 1972; 69: 747
- Goodfriend T. L., Fyhrquist F., Gutmann F., Knych E., Hollemans H, Allman D., Kent K., Cooper T. Clinical and conceptual uses of angiotensin receptors. Hypertension 72, J. Genest, E. Koiw. Springer Verlag, Berlin, Heidelberg, New York 1972
- Hechter O., Calek A. Principles of hormone action: the problem of molecular linguistics. Acta endocr. (Kbh.) 1974; 77: 39
- Hsueh A. J., Peck E. J., Clark J. H. Progesterone antagonism of oestrogen receptor and oestrogen-induced uterine growth. Nature (Lond.) 1975; 254: 337
- Jensen E. V., Brecher P. I., Mohla S., DeSombre E. R. Receptor transformation in oestrogen action. Acta endocr.(Kbh.) 1974; 77(Suppl. 191)159
- Lamberg B. A. Congenital euthyroid goitre and partial peripheral resistance to thyroid hormones. Lancet 1973; 1: 854
- Lee C. Y., Ryan R. J. Radioreceptor assay for human gonadotropin. J. clin. Endocr. 1975; 40: 228
- Lefkowitz R. J. Isolated hormone receptors. Physiologic and clinical implications. New Engl. J. Med. 1973; 288: 1061
- Maass H., Trams G., Nowakovsky H. ötrogenrezeptoren in Mammakarzinom endokrine Therapie. Strahlentherapie 1974; 147: 381
- Milgrom E., Thi L., Atger M., Bailieu E. E. Mechanisms regulating the concentration and conformation of progesterone receptors in the uterus. J. biol. Chem. 1973; 268: 6366
- Rajaniemi H., Rees Midgley A., O'Malley N. W., Hardman J. G. Methods in Enzymology Hormone Action, Part B. Peptide Hormones. Academic Press, New York 1975; Vol. XXXVII
- Refetoff S., DeWind L. T., DeGroot L. J. Familial syndrome combining deaf-mutism, stippled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J. clin. Endocr. 1967; 27: 279
- Rodbard D. Mathematics of hormone-receptor interaction, I. Basic principles. Advanc. exp. med. Biol. 1973; 36: 289
- Roth J. Peptide hormone binding to receptors. A review of direct studies in vitro. Metabolism 1973; 22: 1059
- Roth J. Assay of peptide hormones using cell receptors: Application to insulin and growth hormone. Methods in Enzymology, Vol. XXXVII, Hormone Action, Part B, Peptide Hormones, N. W. O'Malley, J. G. Hardman. Academic Press, New York 1975; 66
- Roth J. Methods for assessing immunologic and biologic properties of iodinated peptide hormones. Metabolism. 223
- Varga J. M., Dipasquale A., Pawalek J., McGuire J. S., Lerner A. B. Regulation of melanocyte stimulating hormone action at the receptor level: Discontinuous binding of hormone to synchronized mouse melanoma cells during the cell cycle. Proc not. Acad. Sci. (Wash.) 1974; 71: 1590